Open access · OA
via OpenAlex
Gut Microbiome Dysbiosis at the Intersection of Obesity, Diabetes, and Colorectal Cancer
NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES · 2025
Epigenetic alterations
Dysbiosis
Altered intercellular communication
Chronic inflammation
Microbiome / FMT
Review
Abstract
The gut microbiome plays a pivotal role in maintaining host metabolic homeostasis, immune function, and intestinal integrity. Dysbiosis being an imbalance in the microbial ecosystem, has been implicated in the pathogenesis of metabolic diseases such as obesity and type 2 diabetes mellitus (T2DM), as well as colorectal cancer (CRC). Emerging evidence reveals intricate crosstalk among these conditions, suggesting that microbiome alterations act as a shared mechanistic link. In obesity and T2DM, gut microbial changes promote chronic inflammation, insulin resistance, and metabolic endotoxemia through increased production of lipopolysaccharide (LPS) and decreased short-chain fatty acids (SCFAs). These same alterations influence colorectal carcinogenesis by disrupting epithelial barrier function, modulating oncogenic signaling, and altering bile acid metabolism. Moreover, gut microbial-derived metabolites can affect epigenetic regulation and immune responses, fostering a tumor-promoting microenvironment. Understanding these interrelationships offers novel insights into disease pathophysiology and highlights the therapeutic potential of microbiota-targeted interventions, including probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT). This review explores the current evidence linking gut microbiome dysbiosis to the obesity-diabetes-CRC axis and discusses future directions for research and therapy. Keywords: Gut microbiome, Dysbiosis, Obesity, Type 2 diabetes mellitus, Colorectal cancer
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.59298/nijses/2025/63.109116
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Nsubuga, E. (2025). Gut Microbiome Dysbiosis at the Intersection of Obesity, Diabetes, and Colorectal Cancer. <em>NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES</em>. https://doi.org/10.59298/nijses/2025/63.109116
Vancouver
Nsubuga E. Gut Microbiome Dysbiosis at the Intersection of Obesity, Diabetes, and Colorectal Cancer. NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES. 2025. doi:10.59298/nijses/2025/63.109116.
BibTeX
@article{ernest2025GutMic,
title = {Gut Microbiome Dysbiosis at the Intersection of Obesity, Diabetes, and Colorectal Cancer},
author = {Ernest Nsubuga},
journal = {NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES},
year = {2025},
doi = {10.59298/nijses/2025/63.109116},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Emerging Trends in Metabolites 2024
Open access · CC-BY
Gut Microbiome Dysbiosis During Metabolic Disorders: Diabetes
Archives of Gerontology and Geriatrics Plus 2025
Open access · CC-BY
Aging through the lens of the gut microbiome: Challenges and therapeutic opportunities
Antioxidants 2024
Open access · CC-BY
Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases
Microbes & Immunity 2026
Open access · CC-BY
Microbial matchmakers: How microbiome dysbiosis fans the flames of chronic inflammation
Diseases (Basel, Switzerland) 2026
Open access · OA
The Microbiota as a Potential Cause of Disease.
Journal of oral microbiology 2025
Open access · OA